Revenue and Profit - Q3 2025 revenue was CNY 150,942,370.11, a decrease of 9.41% year-over-year, while year-to-date revenue increased by 13.53% to CNY 549,873,806.69[4] - Net profit attributable to shareholders for Q3 2025 was CNY 5,834,473.98, up 236.87% year-over-year, and year-to-date net profit increased by 47.10% to CNY 34,848,362.42[4] - Basic earnings per share for Q3 2025 was CNY 0.0788, representing a 294.22% increase year-over-year, with year-to-date earnings per share at CNY 0.4709, up 47.16%[4] - The company reported a 93.23% increase in net profit excluding non-recurring items for Q3 2025, amounting to CNY 4,929,204.40[4] - Net profit for the current period was ¥34,821,061.29, representing a 48.8% increase from ¥23,422,880.63 in the previous period[17] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 2,189,185,264.86, reflecting a 10.26% increase from the end of the previous year[4] - Total current assets increased to ¥1,131,892,557.79 from ¥1,063,088,386.12, reflecting a growth of approximately 6.6%[15] - Total assets reached ¥2,189,185,264.86, up from ¥1,985,396,036.66, indicating an increase of about 10.3%[15] - Total liabilities increased to ¥827,421,339.83 from ¥661,718,705.69, a rise of 25.0%[16] Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 41,285,155.18, an increase of 84.36%[4] - Cash inflow from operating activities totaled ¥433,089,078.12, compared to ¥382,816,328.87 in the previous period, indicating a growth of 13.1%[19] - Net cash flow from operating activities amounted to $41,285,155.18, an increase of 84.4% compared to $22,393,241.08 in the previous period[20] - Cash inflow from investment activities totaled $2,177,787,239.23, up from $1,717,308,599.97, reflecting a growth of 26.8%[20] - Cash inflow from financing activities reached $327,301,378.77, compared to $246,096,038.32, marking an increase of 32.9%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 9,599[11] - The largest shareholder, Cai Danqun, holds 34.89% of shares, totaling 25,820,000 shares, with 2,000,000 shares pledged[11] - The second-largest shareholder, Cai Shaoxin, owns 21.19% of shares, amounting to 15,680,000 shares[11] Inventory and Production - The company experienced a 60.77% increase in inventory, reaching CNY 23,987.40, attributed to increased production[9] - Inventory increased to ¥239,874,047.88 from ¥149,204,013.65, representing a growth of approximately 60.8%[15] Expenses - Total operating costs amounted to ¥515,527,922.51, up from ¥468,169,647.03, reflecting a growth of 10.1%[16] - Research and development expenses were ¥25,133,159.54, slightly down from ¥27,678,651.99, a decrease of 9.2%[17] - The company reported a tax expense of ¥4,018,867.54, compared to ¥1,947,388.68 in the previous period, reflecting a significant increase of 106.0%[17] Cash and Cash Equivalents - The company reported a significant increase in cash and cash equivalents, with a 244.61% rise to CNY 47,888.10 due to the redemption of fundraising cash management products[9] - Cash and cash equivalents rose significantly to ¥478,880,953.18 from ¥138,964,042.14, marking an increase of over 244%[14] - The total cash and cash equivalents at the end of the period stood at $451,390,789.09, a significant increase from $100,922,173.17 in the previous period[20] Financing Activities - Financing activities generated a net cash flow of CNY 13,987.55, a 355.95% increase, primarily due to increased bank loans[10] - Net cash flow from financing activities was $139,875,455.96, up from $30,678,128.48, indicating a substantial improvement[20] Other Information - The company has no preferred shareholders or changes in restricted shares during the reporting period[13] - The company has not disclosed any new product developments or market expansion strategies in the current report[12]
广康生化(300804) - 2025 Q3 - 季度财报